BKV BKV Corp Insider Trading

Eric S Jacobsen (President, Upstream) sold 25,000 shares of BKV at $26.89 on 2026-06-01 via pre-arranged 10b5-1 plan; stock down -15.1% in 30 days.

Eric S Jacobsen sold 25,000 shares worth $672,145.00 on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-11-11, reducing his holdings from 252,843 shares to 227,843 shares. The sale is scheduled and not discretionary. At his prior sale on 2026-05-01, the 30-day return was -14.3%, and this current period shows a 30-day change of -15.1%, consistent with a softer short-term environment for the stock. The company's fundamentals remain solid with annual revenue growth of +47.8%, net income of $44,075,000.00, and a P/E of 9.84, though the stock trades -19.0% from its 52-week high of $32.81 and down -15.2% over 90 days.

BKV upstream president Eric Jacobsen sells ~$774K in shares near 52-week highs amid strong revenue growth.

Eric Jacobsen, BKV's President of Upstream operations, sold a material block of shares worth approximately three-quarters of a million dollars at prices hovering near the company's recent highs, disposing of about 9% of his holdings. The company itself remains financially healthy—profitable with strong recent revenue growth and a reasonable valuation multiple—suggesting this sale is not a distress signal about underlying business fundamentals. However, the timing is noteworthy: the sale occurred when the stock was trading within a fraction of its 52-week peak, which is atypical for insider purchases but common for executives rebalancing portfolios or taking profits after a period of gains. Without additional context on vesting schedules, compensation planning, or concurrent insider activity, this appears to be a routine portfolio adjustment by an operational executive rather than a loss-of-confidence signal.

CEO Kalnin sells 100,000 shares of BKV at $30.06; retains 1,197,243 shares post-sale

Chief Executive Officer Christopher P Kalnin sold 100,000 shares (100.0K shares) of BKV at $30.06 on 2026-03-25, reducing his holdings by 7.7% to 1,197,243 shares (1.20M shares) while retaining a substantial position. The stock is currently trading at $30.14, near its 52-week high of $31.50, following a 10.1% gain over 90 days and a +1.5% move in the past 30 days. The company is trading at a P/E of 8.54 with strong fundamentals: $199.8M in latest-quarter revenue, $76.8M net income, and 47.8% annual revenue growth, indicating robust operational performance. Kalnin's prior BKV trades show inconsistent timing—four of five prior sales occurred in November 2025 with mixed results (ranging from -6.6% to +15.9% over 30 days, and +7.7% to +15.9% over 90 days), with only 1 of 5 prior trades well-timed at the 90-day mark. The current sale at $30.06 occurs near the stock's 52-week high, though whether this disposition signals any particular conviction requires consideration of whether this trade is discretionary or part of a scheduled plan.

BKV Corp CEO Christopher P Kalnin sold 78,281 shares at $28.04 via pre-arranged 10b5-1 plan; retains 1,248,580 shares.

Christopher P Kalnin, BKV Corp's Chief Executive Officer, sold 78,281 shares (78.3K shares) on 2025-11-17 at $28.04, reducing his stake by 5.9% to 1,248,580 shares (1.25M shares). This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-03-14, meaning it was scheduled and non-discretionary rather than a response to current market conditions or company developments. The CEO maintains a substantial post-sale holding of 1,248,580 shares, indicating continued significant personal exposure to the company's performance. Investors should note that as a scheduled plan transaction, this sale carries no timing signal and reflects pre-established execution parameters rather than current strategic positioning.

CEO Kalnin sold 21,719 shares at $28.00 (Nov 14), retaining 1,326,861 shares; stock at 52-week high, revenue down 18.2% YoY.

Kalnin Christopher P, as Chief Executive Officer, sold 21,719 shares at $28.00 on November 14, 2025, representing a 1.6% reduction in his 1.35M-share position. The sale occurred at the 52-week high price of $27.95 (current), marking significant upward momentum following a 30.7% gain over the prior 30 days. However, the company faces material headwinds: annual revenue declined 18.2% year-over-year, the company was unprofitable over its most recent full fiscal year, and the P/E ratio stands at 55.90—substantially elevated relative to profitability metrics. At the same-ticker level, his most recent prior BKV transaction was a buy on 2024-09-27 (90-day return: +25.9%), though his two most recent sales on 2025-11-11 and 2025-11-10 are too recent for outcome measurement. The confluence of a high-priced exit amid fundamental revenue contraction and negative full-year earnings warrants investor attention to the drivers behind recent price momentum.

BKV CEO Kalnin sells 200,000 shares for $5,329,000 via scheduled 10b5-1 plan adopted March 2025

Christopher P Kalnin, CEO of BKV Corp, executed 2 separate sales totaling 200,000 shares for $5,329,000 on November 10-11, 2025, at prices of $26.16 and $27.13 per share. This sale reduces his holdings from 1,548,580 shares to 1,348,580 shares, a decrease of 200,000 shares. The transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-14, meaning the sales were scheduled in advance and not discretionary trading decisions. As a Rule 10b5-1 plan execution, this transaction reflects a programmed divestiture established months prior, and therefore does not constitute a real-time signal of current insider conviction or concern about BKV's valuation or prospects.

Chief Legal and Admin Officer Larrick Lindsay B sold 29,187 shares at $25.00 for $729,688.60 across 2 transactions

Larrick Lindsay B (Chief Legal and Admin Officer) executed 2 separate sales totaling 29,187 shares for $729,688.60 on November 5–6, 2025, reducing his holdings by 17.5% from 166,341 to 137,154 shares. The transaction occurred at $25.00 per share, near the top of the 52-week range ($15.90–$26.49) and above the current price of $24.76. The company reported a net loss over its most recent full fiscal year, though the latest quarter showed $104.6M net income on $207.1M revenue; annual revenue declined 18.2% year-over-year. The significance of this reduction in the chief legal and administrative officer's stake warrants monitoring, particularly given the company's recent profitability swings and contracting top-line growth.

BKV President Jacobsen sells 31,350 shares at $22.02 amid -18.2% revenue decline, unprofitable FY

Jacobsen Eric S, President of Upstream at BKV, sold 31,350 shares at $22.02 on 2025-05-19, reducing holdings by 10.8% to 257,903 shares. The sale occurs in a challenging fundamental environment: the company reported -18.2% annual revenue growth and posted a full-year net loss of $-78,666,000. At current price of $21.93, the stock trades 17.2% below its 52-week high, though it has risen 25.2% over the past 30 days. Jacobsen's prior open-market sell activity shows an average 30-day return of -7.3%, and his two prior BKV sales (most recent on 2025-05-09) do not yet show measurable 90-day outcomes. The sale represents a discrete reduction of insider stake during a period of operational headwinds and negative profitability.

BKV: President Jacobsen sold 31,350 shares at $20.01 under 10b5-1 plan adopted 2024-12-10

President and Upstream executive Eric S Jacobsen sold 31,350 shares at $20.01 on 2025-05-09, reducing his holdings from 320,603 shares to 289,253 shares. This sale is part of a pre-arranged 10b5-1 trading plan adopted on 2024-12-10, making it a scheduled transaction rather than a discretionary trade. The -9.8% reduction in his BKV position is consistent with a plan established months in advance and does not reflect current market conditions or near-term conviction about the stock.

BKV President Jacobsen sells 31,350 shares at $20.06; stock down 35.4% from 52-week high despite recent profitability.

Jacobsen Eric S, President of Upstream, sold 31,350 shares at $20.06 on 2025-04-03, reducing his holdings by 31,350 shares from 351,953 to 320,603 shares. The transaction occurred while the stock trades at $17.11, down 35.4% from its 52-week high of $26.49, a significant deterioration in valuation since his sale date. The company's fundamentals are mixed: while it posted net income of $12,869,000 in the latest quarter, its full-year net income was negative, and annual revenue contracted 18.2% year-over-year, suggesting operational headwinds. The sale price of $20.06 was above current market levels, meaning Jacobsen exited at a premium to today's price, and his remaining 320,603 share position still represents substantial equity exposure to a company facing revenue declines and full-year losses.